Utilizing Bayesian predictive power in clinical trial design

The Bayesian paradigm provides an ideal platform to update uncertainties and carry them over into the future in the presence of data. Bayesian predictive power (BPP) reflects our belief in the eventual success of a clinical trial to meet its goals. In this paper we derive mathematical expressions for the most common types of outcomes, to make the BPP accessible to practitioners, facilitate fast computations in adaptive trial design simulations that use interim futility monitoring, and propose an organized BPP-based phase II-to-phase III design framework.

[1]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[2]  Zhongwen Tang.  Optimal Futility Interim Design: A Predictive Probability of Success Approach with Time-to-Event Endpoint , 2015, Journal of biopharmaceutical statistics.

[3]  Jason T Connor,et al.  The utility of Bayesian predictive probabilities for interim monitoring of clinical trials , 2014, Clinical trials.

[4]  Nigel Stallard,et al.  Decision‐making in a phase II clinical trial: a new approach combining Bayesian and frequentist concepts , 2005 .

[5]  Markus Abt,et al.  Bayesian predictive power: choice of prior and some recommendations for its use as probability of success in drug development , 2016, Pharmaceutical statistics.

[6]  D. Spiegelhalter,et al.  Monitoring clinical trials: conditional or predictive power? , 1986, Controlled clinical trials.

[7]  Markus Abt,et al.  Sequentially updating the likelihood of success of a Phase 3 pivotal time-to-event trial based on interim analyses or external information , 2016, Journal of biopharmaceutical statistics.

[8]  Anthony O'Hagan,et al.  Assurance in clinical trial design , 2005 .

[9]  Bradley P. Carlin,et al.  Bayesian Adaptive Methods for Clinical Trials , 2010 .

[10]  Anastasios A. Tsiatis,et al.  Repeated Significance Testing for a General Class of Statistics Used in Censored Survival Analysis , 1982 .

[11]  A Bound on the Binomial Approximation to the Beta Binomial Distribution , 2008 .

[12]  Draft Guidance.  Adaptive Designs for Clinical Trials of Drugs and Biologics , 2018 .

[13]  D. Spiegelhalter,et al.  A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinion. , 1986, Statistics in medicine.

[14]  John K Kruschke,et al.  Bayesian data analysis. , 2010, Wiley interdisciplinary reviews. Cognitive science.